Skip to main content
Signal8

Bitetti Teresa Marie

SEC insider (Form 3/4/5 filer). CIK 0001977608. President, OBU at TAKEDA PHARMACEUTICAL CO LTD (TAK) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in CAMBRIDGE, MA.

Companies Bitetti Teresa Marie has filed insider reports for

  • TAKEDA PHARMACEUTICAL CO LTD (TAK): Officer, President, OBU
  • Aura Biosciences, Inc. (AURA): Director
Bitetti Teresa Marie profile photo

Bitetti Teresa Marie

CIK: 0001977608

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TAKEDA PHARMACEUTICAL CO LTD logo
TAK

TAKEDA PHARMACEUTICAL CO LTD

Officer
Aura Biosciences, Inc. logo
AURA

Aura Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Aug 10, 2026
    Sale
    Direct
    50K shares at avg. $17.10$855K
  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Jul 1, 2026
    Award
    Direct
    43.9K shares-
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Jun 11, 2026
    Award
    Direct
    15K shares-
  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Apr 27, 2026
    Award
    Direct
    65K shares-
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Mar 31, 2025
    Award
    Direct
    21K shares-

1-5 of 5